Notizie/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivMeno di 1 minuto di letturaCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. Azioni GermaniaAzioni UKAzioni USAEuropaReport finanziariReuters© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlMostra di piùAccedi o crea un account gratuito per leggere queste notizieAndiamo
